From October 1, 2022 to December 20, 2022, the company has repurchased 224,088 shares, representing 1.06% for KRW 3,923.07 million. With this, the company has completed the repurchase of 361,402 shares, representing 1.71% for KRW 6,001.69 million under the buyback announced on September 20, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14,530 KRW | -0.34% | -0.89% | -7.22% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.22% | 225M | |
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B |
- Stock Market
- Equities
- A003220 Stock
- News Daewon Pharmaceutical Co., Ltd.
- Tranche Update on Daewon Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 20, 2022.